Full Text View
Tabular View
No Study Results Posted
Related Studies
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
This study has been completed.
Study NCT00059878   Information provided by National Cancer Institute (NCI)
First Received: May 6, 2003   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection
Additional conditions recognized in this trial
Aspergillosis
Communicable Diseases
Mycoses
Interventions listed in this trial
recombinant interferon gamma
voriconazole
Additional drug interventions recognized in this trial
Interferon Type II
Interferon-gamma, Recombinant
Interferons
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services